Brief: Madrigal Pharmaceuticals Q1 EPS USD -3.32
01/05/2025 12:00
May 01 (Reuters) - Madrigal Pharmaceuticals Q1 net income USD -73.238 million. Q1 operating income USD -79.311 million Q1 operating expenses USD 216.561 million
Recent news on Madrigal Pharmaceuticals
See all newsBrief: Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule
Madrigal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Madrigal Pharmaceuticals Q2 revenue rises 71% on Rezdiffra demand
U.S. RESEARCH ROUNDUP-Boeing, Coca-Cola, PayPal
Brief: Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)